Astrazeneca (AZN) Cash from Operations (2009 - 2025)
Astrazeneca's Cash from Operations was $4.67 billion in Q3 2026, down 9.1% from $5.13 billion a year earlier but up 62.9% from the prior quarter.
Astrazeneca (AZN) Cash from Operations (2009 - 2025) Analysis & Trends
On a trailing twelve-month basis, Astrazeneca's Cash from Operations was $13.23 billion through Sep 30, 2026, down 12.6% year-over-year; for FY2025, it came in at $14.58 billion, up 22.9% from FY2024.
- Cash from Operations has now increased for seven consecutive years, with a five-year compound annual growth rate of 24.9% (FY2020 to FY2025).
- In earlier years, Cash from Operations was $11.86 billion in FY2024 (+14.7%), $10.35 billion in FY2023 (+5.5%), $9.81 billion in FY2022 (+64.5%) and $5.96 billion in FY2021 (+24.3%).
- Quarterly Cash from Operations has moved between $1.25 billion (Q2 2022) and $5.13 billion (Q3 2025) over five years.
- Compared with a year earlier, Cash from Operations has declined for four straight quarters, with growth averaging 8.2% over the last seven quarters.
- The best year-over-year quarter for Cash from Operations over five years was Q2 2024 (growth of 79.6%); the worst was Q4 2021 (a decline of 21.1%).
- Per Business Quant data, AZN's Cash from Operations in the three quarters before Q3 2026 was $2.87 billion (Q2 2026), $3.36 billion (Q1 2026) and $2.34 billion (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Yr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 16.81 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 24.53 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 19.03 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 16.47 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | 19.14 Bn |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 14.58 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 9.96 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 10.02 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 11.70 Bn |
| 10 | Vertex Pharmaceuticals | 138.90 Bn | 106.64 Bn | 2.91 Bn | 3.63 Bn |
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 14.58 Bn |
| Dec 31, 2024 | 11.86 Bn |
| Dec 31, 2023 | 10.35 Bn |
| Dec 31, 2022 | 9.81 Bn |
| Dec 31, 2021 | 5.96 Bn |
| Dec 31, 2020 | 4.80 Bn |
| Dec 31, 2019 | 2.97 Bn |
| Dec 31, 2018 | 2.62 Bn |
| Dec 31, 2017 | 3.58 Bn |
| Dec 31, 2016 | 4.15 Bn |
| Dec 31, 2015 | 3.32 Bn |
| Dec 31, 2014 | 7.06 Bn |
| Dec 31, 2013 | 7.40 Bn |
| Dec 31, 2012 | 6.95 Bn |
| Dec 31, 2011 | 7.82 Bn |
| Dec 31, 2010 | 10.68 Bn |
| Dec 31, 2009 | 11.74 Bn |
Astrazeneca Cash from Operations API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-operations-annual&ticker=AZN&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-operations-annual", "ticker": "AZN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-operations-annual&ticker=AZN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();